All NHS organisations are expected to participate and support health and care research. Conducting high-quality clinical research helps us to keep improving NHS care by finding out which treatments work best. All the practices within Suffolk Primary Care are committed to clinical research. The dedicated Suffolk Primary Care research team may look at your health records to check whether you are suitable to take part in a research study before asking you whether you are interested or sending you a letter on behalf of the researcher. For more information about how your information may be used in research and your rights, please visit https://www.hra.nhs.uk/information-about-patients/
Research in the NHS helps us increase our knowledge about human health and wellbeing so we can:
- Develop life changing treatments
- Diagnose disease earlier and more accurately
- Prevent people from developing conditions
- Improve health and care for future generations
- Improve quality of life for all people
You may be approached by your GP practice about a study if you meet the eligibility criteria for the trial. We have undertaken studies for patients with a number of conditions including stroke, chronic kidney disease, diabetes, chronic obstructive pulmonary disease (COPD) as well as for indigestion and reflux. If you do receive an invitation to take part in a study the research team at Suffolk Primary Care are very happy to talk to you about the study in more detail and provide further information if you are interested in taking part.
Our patients tell us they like being part of research. Following the 2019/2020 CRN Eastern Participant Research Experience Survey, patients have said they have taken part in research because:
- It helps to improve treatments and outcomes for future generations
- They want to give something back to the NHS
- To learn so much more about their own condition
- They feel fortunate to have the opportunity
Join a COIVD-19 Clinical Trial
The PRINCIPLE trial aims to find treatments that reduce hospital admission and improve symptoms for people with COVID-19
You could be eligible to join if you have had these symptoms for fewer than 15 days:
· new continuous cough or high temperature or a loss of, or change in, normal sense of taste or smell
· OR have a positive test for SARS-Co-V2 infection with COVID-19 symptoms in the past 14 days
· You are aged 50 to 64 with a pre-existing illness
· You are aged 65 and above
· To find out more take a look at the study website or contact the PRINCIPLE study team directly on email@example.com • 0800 138 0880
Be a part of COVID-19 Vaccine research
Sign up to the new NHS Covid-19 vaccine research registry – it is available for everyone to join. The registry has been developed in partnership between the National Institute for Health Research (NIHR) and NHS Digital.
The registry will help large numbers of people be recruited into vaccine studies and hopefully lead to an effective vaccine being identified and made available in the UK against COVID-19. For more information: https://www.nhs.uk/sign-up-to-be-contacted-for-research
Clinical research studies that Suffolk Primary Care practices are currently involved in:
ATTACK Aspirin to target arterial events in Chronic Kidney Disease
is a randomised trial run by the University of Southampton to assess the effectiveness of low-dose aspirin to prevent cardiovascular disease in adult patients with reduced kidney function who have not previously had a heart attack or stroke. The aim of the study is to determine whether the benefits of aspirin outweigh any risks in this group of patients. This study has come as a result of recommendations for research in the 2014 NICE CKD Guidelines and it is anticipated that over 25,000 people will be recruited to the study across the UK. This study is being run in all of our of Suffolk Primary Care practices in a rolling programme.
Glucose Lowering through Weight Management.
The University of Cambridge GLoW (Glucose-Lowering through Weight management) trial is aimed at people who have been diagnosed with Type 2 diabetes within the last three years. The GLoW trial will evaluate two programmes which support people with Type 2 Diabetes to improve their diet and physical activity to improve their health. The evidence is that people who lose weight, improve their diet and increase their physical activity reduce the risk of developing health problems associated with diabetes such as heart attack and stroke. The aim of the GLoW study is to determine which programme is the better way for the NHS to improve patient’s health.
How to find out more about research:
‘Be part of research’ helps you find out about health and social care research that is taking place across the UK and provides opportunities to take part in research. https://bepartofresearch.nihr.ac.uk/